- Virginia AG Jason Miyares, along with a bipartisan coalition of eight other state AGs and in coordination with six other AGs, has announced a settlement in principle with Mylan Inc. to resolve allegations that it contributed to the opioid epidemic.
- The AG alleges that Mylan deceptively marketed generic fentanyl patches, oxycodone, hydrocodone, and other opioids as less prone to abuse despite its knowledge that many of these products were more vulnerable to abuse. The AG also alleges that Mylan directly marketed opioids to doctors, which contributed to overprescribing.
- Per the AG’s press release, Mylan will pay up to $335 million to participating states over nine years, with Virginia to receive $6.6 million.
- We previously reported on State AGs’ continued enforcement related to the opioid epidemic, including a $7.4 billion multistate settlement with members of the Sackler family and Purdue Pharma, Inc.; a $272.5 million settlement with Amneal Pharmaceuticals; a lawsuit by Kentucky AG Russell Coleman against a major supermarket; a settlement between Alaska AG Treg Taylor and CVS; and two multistate settlements totaling $500 million with Publicis Health, LLC, and Hikma Pharmaceuticals.